Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Cream

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Triamcinolone Acetonide Cream, 0.1% the generic version of Kenalog Cream, 0.1% of Delcor Asset Corporation (which is no longer being marketed in the United States).

Powered by Capital Market - Live News